These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Simian immunodeficiency virus SIVmac239 infection and simian human immunodeficiency virus SHIV89.6P infection result in progression to AIDS in cynomolgus macaques of Asian origin. Okamura T; Tsujimura Y; Soma S; Takahashi I; Matsuo K; Yasutomi Y J Gen Virol; 2016 Dec; 97(12):3413-3426. PubMed ID: 27902330 [TBL] [Abstract][Full Text] [Related]
4. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693 [TBL] [Abstract][Full Text] [Related]
5. SHIV-C109p5 NHP induces rapid disease progression in elderly macaques with extensive GI viral replication. Bose D; Deb Adhikary N; Xiao P; Rogers KA; Ferrell DE; Cheng-Mayer C; Chang TL; Villinger F J Virol; 2024 Feb; 98(2):e0165223. PubMed ID: 38299866 [TBL] [Abstract][Full Text] [Related]
6. Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques. Mumbauer A; Gettie A; Blanchard J; Cheng-Mayer C J Acquir Immune Defic Syndr; 2013 Apr; 62(5):496-504. PubMed ID: 23221980 [TBL] [Abstract][Full Text] [Related]
7. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif. Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171 [TBL] [Abstract][Full Text] [Related]
8. Revealing uninfected and infected target cell dynamics from peripheral blood data in highly and less pathogenic simian/human immunodeficiency virus infected Rhesus macaque. Hara A; Iwanami S; Ito Y; Miura T; Nakaoka S; Iwami S J Theor Biol; 2019 Oct; 479():29-36. PubMed ID: 31299334 [TBL] [Abstract][Full Text] [Related]
9. Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina). Chen Z; Huang Y; Zhao X; Skulsky E; Lin D; Ip J; Gettie A; Ho DD J Virol; 2000 Jul; 74(14):6501-10. PubMed ID: 10864663 [TBL] [Abstract][Full Text] [Related]
10. Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection. ten Haaft P; Almond N; Biberfeld G; Cafaro A; Cranage M; Ensoli B; Hunsmann G; Polyanskaya N; Stahl-Hennig C; Thortensson R; Titti F; Heeney J J Med Primatol; 2001 Aug; 30(4):207-14. PubMed ID: 11555139 [TBL] [Abstract][Full Text] [Related]
11. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses. Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222 [TBL] [Abstract][Full Text] [Related]
12. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys. Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection. Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828 [TBL] [Abstract][Full Text] [Related]
14. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques. Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675 [TBL] [Abstract][Full Text] [Related]
15. Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein. Silvera P; Richardson MW; Greenhouse J; Yalley-Ogunro J; Shaw N; Mirchandani J; Khalili K; Zagury JF; Lewis MG; Rappaport J J Virol; 2002 Apr; 76(8):3800-9. PubMed ID: 11907220 [TBL] [Abstract][Full Text] [Related]
16. SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine. Cafaro A; Caputo A; Maggiorella MT; Baroncelli S; Fracasso C; Pace M; Borsetti A; Sernicola L; Negri DR; Ten Haaft P; Betti M; Michelini Z; Macchia I; Fanales-Belasio E; Belli R; Corrias F; Buttò S; Verani P; Titti F; Ensoli B J Med Primatol; 2000 Aug; 29(3-4):193-208. PubMed ID: 11085582 [TBL] [Abstract][Full Text] [Related]
17. High viral load and CD4 lymphopenia in rhesus and cynomolgus macaques infected by a chimeric primate lentivirus constructed using the env, rev, tat, and vpu genes from HIV-1 Lai. Dunn CS; Beyer C; Kieny MP; Gloeckler L; Schmitt D; Gut JP; Kirn A; Aubertin AM Virology; 1996 Sep; 223(2):351-61. PubMed ID: 8806570 [TBL] [Abstract][Full Text] [Related]
18. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694 [TBL] [Abstract][Full Text] [Related]